FDA Grants Orphan Drug Status to Investigational Treatment for Spinocerebellar Ataxia - Monthly Prescribing Reference https://t.co/dUI0QImYdu
— IDRO (@IDROOhio) May 31, 2019
from Twitter https://twitter.com/IDROOhio
May 30, 2019 at 10:02PM
Friday, May 31, 2019
FDA Grants Orphan Drug Status to Investigational Treatment for Spinocerebellar Ataxia - Monthly Prescribing Reference https://t.co/dUI0QImYdu
from Twitter https://twitter.com/IDROOhio
May 30, 2019 at 10:02PM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment